Hispanic stroke patients admitted to hospitals in the border states of California, Arizona, New Mexico and Texas were less likely than non-Hispanics in the same border states to receive clot-busting drugs and more likely to die, according to research presented at the American Stroke Association's International Stroke Conference 2014.
Researchers analyzed stroke care for Hispanic and non-Hispanic patients according to demographics and clinical characteristics in states bordering Mexico and states not on the Mexican border. They found:
Note: Actual presentation is 6:10 p.m. PT Thursday, Feb. 13, 201
Follow news from the International Stroke Conference 2014 via Twitter: @HeartNews #ISC14.
Statements and conclusions of study authors that are presented at American Stroke Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding .
B-roll, animation or images related to these tips are on the right column of this link http://newsroom.heart.org/news/thursday-news-tips-2590807?preview=490dfb5c4a43f77e6dae3a3f0029eed2 .
NOTE ALL TIMES ARE PACIFIC (PT). ALL TIPS ARE EMBARGOED UNTIL THE TIME OF PRESENTATION OR 3 P.M. PT/6 P.M. ET EACH DAY, WHICHEVER COMES FIRST. For more information Feb. 12-14, call the ASA News Media Staff Office at the San Diego Convention Center at (619) 525-6204. Before or after these dates, call the Communications Office in Dallas at (214) 706-1173. For public inquiries, call (800) AHA-USA1 (242-8721).